tiprankstipranks
Aptose Biosciences (APTO)
NASDAQ:APTO
Holding APTO?
Track your performance easily

Aptose Biosciences (APTO) Financial Statements

1,246 Followers

Aptose Biosciences Financial Overview

Aptose Biosciences's market cap is currently ―. The company's EPS TTM is $-3.046; its P/E ratio is -0.09; Aptose Biosciences is scheduled to report earnings on March 25, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -6.95M$ -7.25M$ -9.64M$ -11.96M$ -11.45M
EBITDA$ -6.86M$ -7.15M$ -9.53M$ -11.85M$ -11.34M
Net Income Common Stockholders$ -6.95M$ -7.25M$ -9.64M$ -11.96M$ -11.45M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.96M$ 8.33M$ 9.33M$ 9.25M$ 17.72M
Total Assets$ 10.93M$ 10.95M$ 11.95M$ 12.05M$ 20.88M
Total Debt$ 721.00K$ 818.00K$ 919.00K$ 1.01M$ 1.11M
Net Debt$ -7.24M$ -7.51M$ -8.41M$ -8.24M$ -16.61M
Total Liabilities$ 20.06M$ 13.13M$ 12.66M$ 15.89M$ 13.10M
Stockholders Equity$ -9.13M$ -2.18M$ 137.00K$ -2.90M$ 7.78M
Cash Flow-
Free Cash Flow$ -10.38M$ -5.76M$ -11.76M$ -9.26M$ -10.54M
Operating Cash Flow$ -10.38M$ -5.78M$ -11.76M$ -9.26M$ -10.54M
Investing Cash Flow-$ 2.01M$ -1.99M$ 1.94M$ 12.95M
Financing Cash Flow$ 10.01M$ 4.75M$ 11.85M$ 854.00K$ 4.90M
Currency in USD

Aptose Biosciences Earnings and Revenue History

Aptose Biosciences Debt to Assets

Aptose Biosciences Cash Flow

Aptose Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis